![]() |
Volumn 48, Issue 10, 2011, Pages 1058-1062
|
Concomitant asthma medication use by patients receiving omalizumab 20032008
|
Author keywords
Cohort; Guidelines; Insurance claims; Retrospective
|
Indexed keywords
ANTIASTHMATIC AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
METHYLXANTHINE;
OMALIZUMAB;
STEROID;
ADOLESCENT;
ADULT;
ALLERGY;
ARTICLE;
ASTHMA;
CHILD;
COHORT ANALYSIS;
CONTROLLED STUDY;
DRUG APPROVAL;
FEMALE;
HEALTH INSURANCE;
HUMAN;
IMMUNOLOGY;
INFANT;
MAJOR CLINICAL STUDY;
MALE;
PHYSICIAN;
PRESCHOOL CHILD;
PRESCRIPTION;
SCHOOL CHILD;
ADULT;
ANTI-ASTHMATIC AGENTS;
ANTIBODIES, ANTI-IDIOTYPIC;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ASTHMA;
DRUG PRESCRIPTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMANS;
INSURANCE CLAIM REVIEW;
INSURANCE, PHARMACEUTICAL SERVICES;
MALE;
MEDICINE;
|
EID: 82255191085
PISSN: 02770903
EISSN: 15324303
Source Type: Journal
DOI: 10.3109/02770903.2011.631241 Document Type: Article |
Times cited : (5)
|
References (9)
|